UnitedHealth Group (NYSE:UNH) rose 4% in premarket trading Tuesday after the healthcare giant reaffirmed its 2025 earnings guidance and shared positive early results from its Medicare Advantage star ratings.
In an SEC filing, the company projected that by 2027 around 78% of its Medicare Advantage members will be enrolled in plans rated four stars or higher. This level, UnitedHealth emphasized, is “consistent with our expectations and in line with historical performance.”
The firm also confirmed its previously issued forecast for adjusted 2025 earnings per share. That guidance includes the recently completed acquisition of Amedisys, finalized in August 2025. UnitedHealth noted the deal will be slightly dilutive to adjusted EPS in the near term due to financing costs and integration spending.
Star ratings for Medicare Advantage plans, which are scored on a scale from 1 to 5, play a crucial role for insurers. Higher ratings boost government reimbursement, unlock bonus payments, and allow companies to provide additional benefits—factors that can help attract new customers.
UnitedHealth released the update ahead of a series of investor and analyst meetings scheduled from September 8 to 10, where senior executives will outline the company’s strategy, market position, and recent performance.
UnitedHealth Group stock price
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.